|
Non-Vascular Stenting is the use of devices (stents) to
create an artificial pathway, support structure, or opening
for hollow lumen organs that are closed or obstructed due to
cancerous lesions or benign disease.
Non-Vascular Stenting includes, but is not limited to, the
treatment of obstructions in the lungs, esophagus, enteral
(colon and duodenal), and biliary areas.
Stenting has been used in the circulatory system for years
and the majority of people are familiar with coronary and
vascular stenting.
Aveolus is focused on the rapidly emerging market for
Non-Vascular Stenting. Alveolus is leveraging its patent,
patent pending and manufacturing process technology and
relationships to design and develop stenting products for
Interventional Pulmonologist, Gastroeterologists, and
Interventional Radiologist for use in the lungs
(trachea/bronchus), esophagus, enteral (colon and duodenum)
and biliary areas. |
